is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Learn about how G42 Healthcare is running the region’s largest and most comprehensive population genomics program. In addition, discover how insights from population-wide genomics program will impact growth in precision medicine.
G42 Healthcare, a leading AI-powered healthcare company, is on a mission to develop a world-class healthcare sector in the UAE and beyond, by harnessing data and emerging technologies in healthcare to unlock the potential of personalized and preventive care.Agile and futuristic, we have created a transformative shift in the traditional healthcare paradigm.
As a visionary health tech company, we partner with governments, leading international entities, scientists and researchers and the wider medical community who subscribe to our values and our mission as we develop solutions to future-proof the health of nations. We have built Biogenix Labs, UAE’s first COVID-19 accredited large-scale throughput laboratory, and facilitated the 4Humanity clinical trials, the world’s first phase three trial for inactivated vaccine against COVID-19 with over 43,000 volunteers from 125+ nationalities across the pan-Arab region.
From harnessing big data and cloud computing to building the largest biobank in the world, from clinical trials and drug research to delivering healthcare industry solutions that address near- and long-term opportunities, our robust pipeline of offerings across the entire healthcare value chain will transform the future of healthcare.